Implementing a personalized pharmaceutical plan in kidney or liver transplant patients: study protocol for a stepped-wedge cluster randomized trial (GRePH)
This study is a stepped-wedge cluster randomized trial with transplantation units defining clusters. Twelve clusters from 10 university hospitals were recruited. All centres started on the same day in the control phase. Every 7 weeks, one centre will switch to the intervention phase and remain there until the end of inclusions. We plan to recruit 1716 kidney and/or liver transplant patients. The intervention phase consists in setting up the PPP: development of the patient ’s hospital and community pharmaceutical follow-up. In the hospital, the pharmacist will carry out drug reconciliation upon admission, daily pharmaceut...
Source: Trials - November 8, 2021 Category: Research Source Type: clinical trials
Post-COVID-19 Monitoring in Routine Health Insurance Data
Conditions: Virus Diseases; Epidemiology Intervention: Other: Exposed to a SARS-CoV-2 infection Sponsors: Technische Universität Dresden; InGef - Institut für angewandte Gesundheitsforschung Berlin GmbH; BARMER Institut für Gesundheitssystemforschung (bifg); AOK Bayern - Die Gesundheitskasse; AOK PLUS; DAK Gesundheit; Techniker Krankenkasse Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2021 Category: Research Source Type: clinical trials
Use of Continuous Glucose Monitors in Publicly-Insured Youth With Type 2 Diabetes - A Pilot and Feasibility Study
Condition: Type 2 Diabetes Interventions: Device: Continuous Glucose Monitor; Other: Patient Reported Outcome Questionnaires Sponsor: Stanford University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2021 Category: Research Source Type: clinical trials
Post-COVID-19 Monitoring in Routine Health Insurance Data
Conditions: Virus Diseases; Epidemiology Intervention: Other: Exposed to a SARS-CoV-2 infection Sponsors: Technische Universität Dresden; InGef - Institut für angewandte Gesundheitsforschung Berlin GmbH; BARMER Institut für Gesundheitssystemforschung (bifg); AOK Bayern - Die Gesundheitskasse; AOK PLUS; DAK Gesundheit; Techniker Krankenkasse Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2021 Category: Research Source Type: clinical trials
Use of Continuous Glucose Monitors in Publicly-Insured Youth With Type 2 Diabetes - A Pilot and Feasibility Study
Condition: Type 2 Diabetes Interventions: Device: Continuous Glucose Monitor; Other: Patient Reported Outcome Questionnaires Sponsor: Stanford University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2021 Category: Research Source Type: clinical trials
Post-COVID-19 Monitoring in Routine Health Insurance Data
Conditions: Virus Diseases; Epidemiology Intervention: Other: Exposed to a SARS-CoV-2 infection Sponsors: Technische Universität Dresden; InGef - Institut für angewandte Gesundheitsforschung Berlin GmbH; BARMER Institut für Gesundheitssystemforschung (bifg); AOK Bayern - Die Gesundheitskasse; AOK PLUS; DAK Gesundheit; Techniker Krankenkasse Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2021 Category: Research Source Type: clinical trials
